1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Complement component 5 deficiency: new trials by email Literature Review of Complement component 5 deficiency trials Research Report on Complement component 5 deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRIDERM D.S. Crema Normalizzante for Neonatal Hyperseborrhea (Cradle Cap) and Associated Cutaneous Manifestations of Mild-to-Moderate Seborrheic Dermatitis in Children Aged 0 to 3 Years TRIDERM D.S. Crema Normalizzante - Cradle Cap, Seborrheic Dermatitis | Not applicable | Not yet recruiting | ICIM International S.r.l. | 20 | 2026-10-01 | 2026-10-06 |
| Promiseb Topical Cream for Cradle Cap Promiseb Topical Cream, Bland emollient - Cradle Cap, Infantile Seborrheic Dermatitis | Phase 4 | Completed | Promius Pharma, LLC | 42 | 2010-03-01 | 2017-03-07 |
Dermatitis, Seborrheic (2) · Erythema (1)
Dermatitis (2) · Sebaceous Gland Diseases (2) · Skin Diseases (2) · Skin Diseases, Eczematous (2) · Skin Diseases, Papulosquamous (2) · Skin and Connective Tissue Diseases (2) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Manifestations (1)
ICIM International S.r.l. (1) · Promius Pharma, LLC (1)
Italy (1) · United States (1)